Search - tctmd.com

Displaying 461 - 480 of 599

Sort: Relevancy | Date

News Conference News ESC 2015

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

Caitlin E. Cox

August 30, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Daily News

国际性研究认为治疗差异与急性心梗患者死亡率存在关联

Yael L. Maxwell

August 14, 2015

News Daily News

Un Estudio Internacional Vincula las Variaciones de Tratamiento con la Mortalidad en el Manejo de IAM

Yael L. Maxwell

August 14, 2015

News Daily News

International Study Links Treatment Variations to Mortality in Acute MI

Yael L. Maxwell

August 14, 2015

News Daily News

急性心梗后进行心脏康复治疗这一实践仍未在年长患者中充分普及

Yael L. Maxwell

August 07, 2015

News Daily News

Un Estudio Identifica las Disparidades de Supervivencia Tras sufrir un IAM(1)

Yael L. Maxwell

August 07, 2015

News Daily News

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

Yael L. Maxwell

August 07, 2015

News Daily News

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

August 04, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Daily News

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

August 04, 2015

News Daily News

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

Yael L. Maxwell

July 31, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Yael L. Maxwell

July 31, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Industry News

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

July 22, 2015

Advertisement

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

国际性研究认为治疗差异与急性心梗患者死亡率存在关联

Un Estudio Internacional Vincula las Variaciones de Tratamiento con la Mortalidad en el Manejo de IAM

International Study Links Treatment Variations to Mortality in Acute MI

急性心梗后进行心脏康复治疗这一实践仍未在年长患者中充分普及

Un Estudio Identifica las Disparidades de Supervivencia Tras sufrir un IAM(1)

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content